title: Treatment of giant papillary conjunctivitis with cromolyn sodium.
abstract: We evaluated the efficacy of cromolyn sodium in the management of contact lens patients with GPC. Fourteen of 20 patients (70%) with moderate to severe giant papillary conjunctivitis (GPC) were able to continue wearing contact lenses with the use of 4% sodium cromolyn eye drops. These patients had all failed to stay symptom free with our standard method of treatment (i.e., discontinuing contact lens wear for 1-2 weeks; improving lens care; and refitting with different lens designs and/or polymers). This study examined the indications, therapeutic regimen, complications, and patient response to the use of sodium cromolyn in contact lens patients with GPC.
authors.affiliation: Department of Surgery, University of Connecticut School of Medicine, Farmington.
authors.forename: C J
authors.initials: CJ
authors.lastname: Kruger
authors.forename: W H
authors.initials: WH
authors.lastname: Ehlers
authors.forename: A E
authors.initials: AE
authors.lastname: Luistro
authors.forename: P C
authors.initials: PC
authors.lastname: Donshik
mesh_terms: D000328:Adult; D003233:Conjunctivitis, Allergic / Q000188:drug therapy*; D003261:Contact Lenses; D004205:Cromolyn Sodium / Q000009:adverse effects / Q000627:therapeutic use*; D005141:Eyelid Diseases / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D017060:Patient Satisfaction; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D004205:Cromolyn Sodium